BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Acivicin

(N-(4-amino-4-deoxy-N(10)-methylpteroyl)amino)-3-chloro-4,5-dihydro-5-isoxazoleacetic acid [Supplementary Concept] analog of methotrexate with acivicin replacing glutamate; structure given in first source

126+ PubMed studies analyzed · 4 RCTs · Evidence Score: 40.8

Research Domains

Acivicin has been studied across 11 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🫘 Kidney, 🔥 Metabolic, 🏋️ Muscle & Hypertrophy. The primary research focus is 🔬 Oncology with 53% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Acivicin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Butaclamol
4 shared targets
Tomatine
4 shared targets
Arsenic
3 shared targets
Cetomacrogol
3 shared targets
pyrrolnitrin
4 shared targets
Methylnitronitrosoguanidine
4 shared targets
Testolactone
2 shared targets
Trabectedin
5 shared targets
Furazolidone
4 shared targets
Esculin
2 shared targets
Loading evidence profile...

This evidence profile for Acivicin is generated deterministically from 126 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.